Acute liver injury causes massive hepatocyte apoptosis and/or fatal liver damage. Fibronectin, an extracellular matrix glycoprotein, is prominently expressed during adult tissue repair. However, the extent of fibronectin dependence on the hepatocyte response to acute liver damage remains to be defined. As identification of hepatic survival factors is critical for successful therapeutic intervention in liver failure, this relationship has been investigated using a fibronectin-deficient mouse model of acute liver injury. Here we show that the lack of fibronectin induces significantly increased hepatocyte apoptosis, which is accompanied by significant downregulation of the anti-apoptotic protein Bcl-xL.
Introduction
Acute liver injury caused by the hepatitis virus or hepatotoxins induces massive hepatocyte apoptosis and/or fatal liver damage, and eventually liver transplantation is required (1) (2) . Identification of hepatic survival factors is critical for successful therapeutic intervention in liver failure. Following acute injury, the liver undergoes a wound healing response to restore tissue architecture and maintain homeostasis (3) . Liver regeneration requires both a well-orchestrated proliferation of hepatocytes and the reconstruction of the extracellular matrix (ECM). In response to injury, the "provisional matrix" formation between plasma fibrin(ogen) and plasma-type fibronectin during an initial stage stabilizes wound areas and provides a road map for cell migration (4) . The components of this provisional matrix, plasma fibrinogen and plasma-type fibronectin, are produced by hepatocytes in the liver (4) (5) (6) .
Fibronectin is a large dimeric glycoprotein that exists in soluble form as a plasma component and in insoluble form as a part of the ECM of almost every tissue (5) (6) . Both isoforms are generated from a single gene by alternative splicing (7) . Extensive in vitro functional studies have indicated that fibronectin plays key roles in a wide variety of cellular behaviors (5) (6) . Prominent expression of fibronectin is observed during tissue repair, including liver injury (8) (9) . To explore the function of fibronectin in adult tissues, we generated plasma-type fibronectin conditional-knockout mice and demonstrated that plasma-type fibronectin supports neuronal cell survival following brain damage but is not essential for skin-wound healing (10) . To further define the functional identity of fibronectin in the initial stage of adult tissue remodeling, a null-condition for both plasma and cellular fibronectin isoforms from adult liver was recently established in our group. We showed that, in contrast to the long-standing concept that collagen fibril assembly requires fibronectin matrix in culture (11) (12) (13) , the lack of fibronectin does not actually interfere with reconstruction of collagen organization in the initial fibrogenic response to liver damage (14) .
The functional role of fibronectin in parenchymal cells (hepatocytes) following liver injury remains obscure, but regulation of hepatocyte proliferation has been suggested. The level of fibronectin mRNA during liver regeneration after partial hepatectomy is upregulated 3-fold in the liver (15) , and fibronectin can promote epidermal growth factor (EGF)-initiated DNA synthesis in primary hepatocyte cultures (16) . However, the extent of fibronectin dependence on the hepatocyte response to acute liver damage
has not yet been addressed. Here, using a mouse model lacking fibronectin in the adult liver, the suitability of fibronectin as a target for promoting hepatocyte survival and proliferation following acute liver injury has been investigated.
Materials and Methods

Mutant mice generation and mouse maintenance
A mouse strain carrying the fibronectin-floxed gene (Fn[fl/fl]) was generated. Mice lacking both plasma and cellular type fibronectin ('Liver fibronectin-null mice') were established by intraperitoneal injections of polyinosinic-polycytidic acid (pI-pC) in the Fn(fl/fl)/Mx-Cre+ strain (C57BL6/129sV mixed background) as described previously (14) . Fibronectin-null livers showed normal liver morphology, and no obvious inflammation or fibrosis was noted after pI-pC injections (14) . All mice were maintained and bred at the Cleveland Clinic's Biological Resources Unit in accordance with institutional guidelines and National Institutes of Health standards. The study was approved by the Institutional Animal Care and Use Committee. Mice were regularly monitored and had free access to standard mouse chow and water. Mice received humane care in accordance with institutional guidelines and National Institutes of Health recommendations outlined in the "Guide for the Care and Use of Laboratory Animals."
Induction of acute liver injury by carbon tetrachloride (CCl 4 )
Acute liver injury was induced by a single intraperitoneal dose administration of CCl 4 solution in olive oil (Fluka) (1.0 ml/kg body weight as 50% [vol/vol]) in sex-matched, 12-to 15-week-old mice as described previously (14, 17) . Control and liver Fn-null mice were derived from the same litters.
Antibodies, cytokines and reagents
The following antibodies were used for the analyses: rabbit polyclonal antibody (pAb) against mouse fibronectin (Chemicon); goat pAb against fibrinogen (Nordic Immuno. Lab.); rabbit mAb (E184, Epitomics) against alpha smooth muscle actin (α-SMA); rabbit mAb against Ki67 (clone SP6, Lab Vision); rabbit pAb against cleaved caspase 3 (Cell Signaling); mouse mAb against phospho- 
Histological analysis, immunohistochemistry and immunofluorescence
Histological analysis, immunohistochemistry and immunofluorescence were performed as described previously (14, 18) . To quantify damaged areas in response to acute liver injury, images were captured with the same gain, offset, magnitude and exposure time. A minimum of 5 different images from each mouse were randomly selected and the intensities were quantified using Image-Pro Plus software (version 6.1, Media Cybernetics) as described previously (17) . For quantification of Bcl-xL signal intensity in primary hepatocytes, images were captured with the same gain, offset, magnitude and exposure time. Then 6 areas per image were randomly selected, and the mean intensity in each cell (intensities/areas, 50 cells) was measured using Image-Pro Plus. The average intensity per cell (relative fluorescent units) was calculated as described elsewhere (19) .
Western-blot analysis
Western blot analyses were performed as described elsewhere (14) . In some immunoblotting analyses, samples were transferred onto Immobilon-FL polyvinylidene fluoride (PVDF) membrane (Millipore Corp.) and probed with primary and IRDye 800CW-or IRDye 680-conjugated secondary antibodies (LI-COR Biosci.). Immunoreactive bands were detected using the Odyssey Infrared Imaging System (LI-COR Biosci.).
Enzyme-linked immunosorbent assay (Elisa) for hepatocyte growth factor (HGF)
The amount of HGF in liver samples was determined using an Elisa kit (Institute of Immunology, Japan) according to the manufacturer's instructions.
Serum biochemical analysis
Serum alanine aminotransferase (ALT) levels were determined using a standard kit (Genzyme Diagnostics P.E.I. Inc., Canada).
In vitro assay using mouse primary hepatocytes
Primary hepatocytes were isolated from adult fibronectin-null mouse livers using collagenase perfusion and suspended in Williams' E medium supplemented with 5µg/ml insulin, 5µg/ml transferrin, 10ng/ml EGF, 10 
Data presentation and statistical analysis
All experiments were performed in triplicate as a minimum, on separate occasions, and the data shown were chosen as representative of results consistently observed. Results are presented as means ± standard deviation (S.D.). Differences between groups were analyzed using the two-sided Student's t test on raw data. A P value of <0.05 was considered significant. 
Results
Fibrin(ogen)-matrix formation without fibronectin in response to acute liver injury
The initial responses to tissue damage are 1) an exudation of plasma proteins and 2) formation of a provisional matrix composed of plasma fibrin(ogen) and fibronectin. Therefore, it was first examined whether the deposition and tissue distribution pattern of the provisional matrix were altered in fibronectin-null livers following acute injury. The expression of fibrin(ogen) showed similar levels between control and mutant livers before and after liver injury (up to 72hrs) by western analysis (Fig.   1A ). In control livers, intense deposition of fibronectin and fibrin(ogen) was observed following injury, and was often co-localized as evidenced by yellow fluorescence in merged images ( Bcl-xL is an anti-apoptotic member of the Bcl-2 (B-cell lympohoma-2) family of proteins and is the guardian of the mitochondrial pathway for cell death (24) . Since Bcl-xL is up-modulated during liver regeneration (25) , the expression of Bcl-xL in fibronectin-null livers following injury was examined. The expression level of Bcl-xL protein was remarkably downregulated by ~55.6% and ~50.0% in fibronectinnull livers at 24hr and 36hr post injury, respectively, by western analysis (Fig. 2C) 2D ,E). These findings suggest that fibronectin plays an important role in supporting hepatocyte survival following acute liver injury.
Lack of fibronectin leads to significantly increased hepatocyte proliferation with increased levels of HGF following acute liver injury.
CCl 4 is primarily cytotoxic to hepatocytes and causes centrilobular hepatocellular necrosis. The responses to carbon tetrachloride CCl 4 -induced acute liver injury are the hepatocyte necrosis that is followed by the subsequent hepatocyte regeneration, and there is an overlapping in these two processes (26) (27) . Since fibronectin deficiency resulted in significantly increased apoptosis in hepatocytes post injury ( Fig. 2A,B) , we hypothesized that the absence of fibronectin may result in elevated liver damage. Serum alanine aminotransferase (ALT) levels (a marker for hepatocyte injury)
did not show significant differences between mutant and control livers and their peak was ~36hrs.
However, a slight elevation in mutant livers was observed at 24 and 36hrs post injury (~12% (Fig. 5A (14) ). Since cross-talk between hepatic stellate cells and hepatocytes drives hepatocyte proliferation and liver regeneration (29) (30) , an increased amount of diffusible factor secreted from activated hepatic stellate cells in fibronectin-null livers was proposed as a paracrine mediator for enhanced hepatocyte proliferation following injury. One of the key mediators in promoting hepatocyte proliferation is HGF and activated hepatic stellate cells are the major cellular source of HGF, including in CCl 4 -induced liver damage (31) (32) . HGF binds to cell surface receptor Met and such ligand-binding triggers trans-phosphorylation of Met tyrosine residues. Significantly elevated HGF levels in fibronectin-null livers at 36hrs post injury (~1.7-fold increase, P<0.01) were found (Fig. 5B) . Indeed, double immunofluorescence staining revealed a specific colocalization of HGF with α-SMA in mutant livers at 36hrs post injury (Fig. 5C ). Furthermore, a specific colocalization of phosphorylated-Met with the hepatocyte marker albumin was confirmed in mutant livers (Fig. 5D) .
In response to liver injury, HGF-Met binding leads to the activation of intracellular signaling pathways that involve Ras/extracellular signal-regulated kinase (Erk) and PI3K/Akt pathways, which thereby provide clues to the initiating signals for hepatocyte proliferation (29, (33) (34) . Considerable phosphorylation of Erk1/2 was observed in fibronectin-null livers (~9.3-and ~7.7-fold induction at 36 and 48hrs post injury, respectively, compared with 0hr [untreated]) with the induction peak around 36hrs. In contrast the pErk1/2 induction levels in control livers were remarkably lower (~3.5-and ~1.9-fold induction at 36 and 48hrs post injury, respectively, compared with 0hr [untreated]). The Erk1/2 phosphorylation levels between control and fibronectin-null livers at each time point did not show significant differences (Fig. 6A) . However, importantly, immunohistochemical observation revealed that the number of pERK-positive hepatocytes in fibronectin-null livers was significantly higher compared with controls at both 36 and 48hrs post injury (Fig. 6B,C) . PI3-kinase/Akt and focal adhesion kinase (FAK)/p53 pathways are involved in transduction of survival signals (22, 35) . There were no obvious differences in the levels of phosphorylated Akt except that mutant livers showed decreased phosphorylation (~1.7-fold reduction) at 24hrs post injury (Fig. 6A) . The expression levels of p53 post injury were similar between control and mutant livers (Fig. 6A ). These findings indicate that fibronectin is not essential for hepatocyte proliferation and suggest that the PI3-kinase/Akt pathway might play a role in hepatocyte apoptosis following acute liver injury.
Fibronectin-mediated matrix-survival signal is transduced through the PI3-kinase-Bcl-xL signaling axis in primary hepatocytes in vitro.
There is evidence that reactive oxygen species (ROS) are produced in hepatocytes following CCl 4 -induced liver injury and such ROS have cytotoxic effects on hepatocytes (36) . To further determine whether fibronectin is directly involved in the Bcl-xL-mediated anti-apoptotic effects on hepatocytes, in vitro studies were performed with the potent ROS inducer H 2 O 2 . Fibronectin-null primary hepatocytes were used to exclude an endogenous production of cellular fibronectin. When these cells were plated on type I collagen and on fibronectin-coated substrata, the number of Bcl-xL-positive hepatocytes and
Bcl-xL expression levels were similar in both conditions (Fig. 7A,B) . However, when plated following 1 mM H 2 O 2 treatment, the number of Bcl-xL-positive hepatocytes and Bcl-xL expression levels were significantly higher on fibronectin (Fig. 7A,B) . Since the decreased Akt phosphorylation was noted in mutant livers at 24hrs post injury (Fig. 6A) , the transduction pathway for survival signals from fibronectin was investigated. Indeed, application of PI3-kinase inhibitor LY294002 (5µM; IC50=1.4µM) following H 2 O 2 treatment significantly inhibited (~60.0%) Bcl-xL expression on fibronectin (Fig. 7C ).
MEK1/2 inhibitor PD98059 (up to 20µM; IC50=2µM), JNK inhibitor 420119 (up to 1µM; IC50=40nM), and p38 MAP kinase inhibitor SB203580 (up to 5µM; IC50=34nM) had no obvious effect on Bcl-xL expression on fibronectin (Fig. 7C and data not shown) . Taken together, these results indicate that a deficiency in fibronectin leads to lack of fibronectin-mediated matrix-survival signals transduced through the PI3-kinase-Bcl-xL signaling axis and induces hepatocyte apoptosis in response to acute liver damage.
Discussion
In the current study, evidence is provided that shows 1) a deficiency in fibronectin induces significantly increased hepatocyte apoptosis, which is accompanied by a significant downregulation of Bcl-xL protein expression; 2) a lack of fibronectin leads to an earlier onset of regeneration and an accelerating hepatocyte proliferation with increased levels of HGF; and 3) fibronectin-mediated matrix-survival signals are transduced through the PI3-kinase-Bcl-xL signaling axis in primary hepatocytes in vitro. We clearly demonstrate the functional links between fibronectin and hepatocyte survival both in vivo and in
vitro.
Since skin wounds heal normally in mice lacking plasma-type fibronectin (10), an absolute requirement for fibronectin in response to adult tissue damage has been speculative. Although there is a study showing that exogenously administered plasma-type fibronectin can prevent Dgalactosamine/lipopolysaccharide-induced lethal hepatic failure in mice (37), the high level of fibronectin used for the analysis (~4mg/ml) is far beyond physiological levels (~200µg/ml in normal plasma (38)). This present genetic study with a fibronectin-deficient model provides compelling evidence that fibronectin acts as an anti-apoptotic factor for hepatocytes in response to acute liver Accumulating evidence proposes that apoptosis and cell proliferation are closely linked. Indeed, Bcl-2 family members play dual roles, serving as mediators of both processes, with the expression of antiapoptotic Bcl-xL retarding cell cycle progression (43) (44) . However, in contrast to the anti-apoptotic function mediated by the fibronectin/Bcl-xL signaling axis following liver injury, the lack of fibronectin 12 resulted in earlier onset of regeneration and the acceleration of hepatocyte proliferation. This is contrary to in vitro evidence that fibronectin can promote EGF-initiated hepatocyte proliferation in culture (16) .
We have previously demonstrated that the lack of fibronectin in the liver shows elevated active TGF-β levels in response to CCl 4 -induced acute liver injury, which results in more activation and proliferation of hepatic stellate cells (14) . In the present study, significantly elevated levels of HGF produced by hepatic stellate cells were found in fibronectin-null livers following injury, and this is a known key mediator for promoting hepatocyte proliferation (29, 34) . Therefore, these findings support the following hypothesis:
Although fibronectin plays a pivotal role in protecting against hepatocyte apoptosis following acute liver damage, a deficiency in fibronectin results in elevated activation and proliferation of hepatic stellate cells and thereby increased HGF production, which in turn surpasses the fibronectin-mediated hepatocyte proliferation activity. Ultimately, greater activity of the Erk pathway, as suggested by higher phosphorylation levels at 36 and 48hrs in fibronectin-null livers, enhances hepatocyte proliferation and results in significantly smaller damaged areas at 72hrs post injury. Thus, fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in response to acute liver injury. (A) Western blot analysis of phospho-ERK (pERK), total ERK, phospho-Akt (pAkt), total Akt, p53, and HSC70 (loading control) in control and mutant livers. Pooled samples from 3 mouse livers from each strain were used for the analysis. Band intensity was measured by densitometry, and each pERK and pAkt intensity was normalized to total ERK and total Akt, respectively; each p53 intensity was normalized to HSC70. Then the intensity at 0hr in the control liver was set to 1. Each intensity is shown relative to the control value. 
